VICO Therapeutics
vicotx.comVico Therapeutics is committed to advancing RNA modulating therapies for patients with severe, genetic neurological disorders. Vico is initially targeting Spinocerebellar Ataxia Types 3 and 1 and Huntington’s Disease. Our Vicomer platform designs antisense oligonucleotides for various genetic defects by modulating or editing RNA. For more information, visit www.vicotx.com.
Is this your company?
If you're responsible for hiring at this company, make sure your company and job information are always up to date to attract top talent from the Up!Rotterdam network.
Something looks off?
Open jobs at VICO Therapeutics
On-site & Remote
Seniority
Salary